太龙药业(600222.SH)发布半年度业绩，归母净利润1935万元，同比下降27.32%

Group 1 - The company reported a revenue of 762 million yuan for the first half of 2025, representing a year-on-year decrease of 17.77% [1] - The net profit attributable to the parent company was 19.35 million yuan, down 27.32% year-on-year [1] - The net profit after deducting non-recurring items was 15.19 million yuan, reflecting a year-on-year decline of 40.64% [1] - The basic earnings per share were 0.0350 yuan [1]